| |
|
|
|
ADMA Biologics Inc.  
|
|
5.24 0.11 (0.02%) |
09-17 16:00 |
|
Open: |
5.12 |
Pre close: |
5.13 |
Target:
|
6.41
|
|
High: |
5.39 |
Low: |
5.0975 |
Resistance:
|
5.48
6.41
|
|
Volume: |
554,788 |
Market Cap: |
311M |
Support:
|
4.36
 3.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.22
|
MACD |
MACD(12,26):
|
0.36 |
|
MA(20): |
4.60 |
Signal(12,26,9): |
0.30 |
|
MA(100): |
4.13 |
Stochastic Oscillator |
%K(14,3):
|
77.38 |
|
MA(250): |
4.32  |
%D(3): |
79.43 |
|
Average Volume(K) |
3-Month: |
70254
|
52-Week |
High:
|
6.72 |
|
10-Days: |
97020 |
Low: |
2.08 |
|
RSI |
RSI(14):
|
70.28 |
Change(%): |
-19.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.240 |
Return on Equity (ttm) |
-120.5 |
Shares Out. (M) |
59.32 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-26.3 |
Shares Float (M) |
26.08 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
25.50 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
40.9 |
% Held by Institutions |
57.51 |
|
Forward EPS |
-0.390 |
Gross Profit (p.s.) |
-0.425 |
Shares Short (K) |
4750 |
|
Book Value (p.s.) |
0.790 |
EBITDA (p.s.) |
-0.878 |
P/E |
-4.23 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.63 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-64.25 |
P/S |
817991552.00 |
|
Operating Margin |
-298.68 |
Levered Free Cash Flow
(M) |
-42.17 |
P/CF |
-4.84 |
|
|
|
|
|
|
